Cytokinetics Presents Additional Data Related to Aficamten at the European Society of Cardiology Heart Failure 2025 Congress

Two New Analyses from SEQUOIA-HCM on Effect of Aficamten Between Patients
with Mild and Moderate-to-Severe Symptoms, and Across Geographic Regions